References
- American Medical Association Code of Medical Ethics. Available at: http://www.ama-assn.org/apps/pf_new/pf_online?category=CEJA&assn=AMA&f_n=mSearch&s_t=&st_p=&nth=1&. [Last accessed 11 February 2008]
- American Society of Health-System Pharmacists. ASHP guidelines on pharmacists’ relationships with industry. Am J Hosp Pharm. 1992; 49:154
- Food and Drug Administration Amendments Act of 2007, H.R. 3580. Available at: http://www.fda.gov/oc/initiatives/HR3580. pdf. [Last accessed 11 February 2008]
- Office of Inspector General. OIG Compliance Program Guidance for Pharmaceutical Manufacturers. Fed Reg 2003;68(86) May 5:23731–43
- Pharmaceutical Research and Manufacturers of America. PhRMA Code on Interactions with Healthcare Professionals. Washington DC, January 2004. Available at: http://www.phrma.org/files/PhRMA%20Code.pdf. [Last accessed 12 February 2008]
- International Federation of Pharmaceutical Manufacturers and Associations (IFMPA) Code of Pharmaceutical Marketing Practices. 2006 Revision. Available at: http://www.ifpma.org/pdf/IFPMA-TheCode-FinalVersion-30May2006-EN.pdf. [Last accessed 12 February 2008]
- European Federation of Pharmaceutical Industries and Associations (EFPIA) Code on the Promotion of Prescription-Only Medicines to, and Interactions With, Healthcare Professionals. October 2007. Available at: http://www.efpia.org/0bjects/2/Files/code%20 medicines%202007.pdf. [Last accessed 12 February 2008]
- European Federation of Pharmaceutical Industries and Associations (EFPIA). Annual meetings 2007, Brussels, 31 May 2007. No. 2. Available at: http://212.3.246.100/Objects/2/Files/2007newsletter2.pdf. [Last accessed 12 February 2008]
- International Committee of Medical Journal Editors Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. Updated October 2007. Available at: http://www.icmje.org/. [Last accessed 11 February 2008]
- Wager E, Field EA, Grossman L. Good publication practice for pharmaceutical companies. Curr Med Res Opin 2003;19:149–54
- Jacobs A, Wager E. European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications. Curr Med Res Opin 2005;21:317–22
- Norris R, Bowman A, Fagan JM, et al. International Society for Medical Publication Professionals (ISMPP) position statement: the role of the professional medical writer. Curr Med Res Opin 2007;23:1837–40
- Graf C, Wager E, Bowman A, et al. Best practice guidelines on publication ethics: a publisher’s perspective. Int J Clin Pract 2007;61(Suppl 152):1–26
- The Prescription Project. Available at: http://www.prescriptionproject.org/. [Last accessed 12 February 2008]
- Brennan TA, Rothman DJ, Blank L, et al. Health industry practices that create conflicts of interest. A policy proposal for academic medical centers. JAMA 2006;295:429–33
- The Physician Payments Sunshine Act. S.2029. Grassley-Kohl Bill. September 6, 2007. Available at: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=110_cong_bills&docid=f:s2029is.txt. pdf. [Last accessed 12 February 2008]
- Association of American Medical Colleges. Protecting Subjects, Preserving Trust, Promoting Progress-Policy and Guidelines for the Oversight of Individual Financial Interests in Human Subjects Research, December 2001. Available at: http://aamc.org/research/ coi/firstreport.pdf. [Last accessed 11 February 2008]
- Policy and Guidelines for Interactions between the Stanford University School of Medicine, the Stanford Hospital and Clinics, and Lucile Packard Children’s Hospital with the Pharmaceutical, Biotech, Medical Device, and Hospital and Research Equipment and Supplies Industries (“Industry”), October 2006. Available at: http://med.stanford.edu/coi/siip/policy.html. [Last accessed 12 February 2008]
- University of Washington School of Medicine Ghost Authorship Policy. August 1, 2007. Available at: http://depts.washington.edu/clinres/pdfs/SOMGhostAuthorshipPolicy2007.pdf [Last accessed 12 February 2008]
- Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases. European Federation of PharmaceuticalIndustries andAssociations (EFPIA), International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Japanese Pharmaceutical Manufacturers Association (JPMA), and Pharmaceutical Research and Manufacturers of America (PhRMA) January 2005. Available at: http://members.phrma.org/publications/policy//admin/2005–01–06.1113.PDF. [Last accessed 9 August 2007]